fffffff fffffffffffffffffffffffffffffffffffffffaTreponema ... · hfor Treponema pallidium...
Transcript of fffffff fffffffffffffffffffffffffffffffffffffffaTreponema ... · hfor Treponema pallidium...
4747
I N N O - L I A ™ S y p h i l i s S c o r e©
fFuj
ireb
iofE
urop
ef20
14f-
INN
O-L
IA™
fSC
OR
EfS
AS
LinefimmunoassayfforfthefconfirmationfoffantibodiesftofffffffffffffffffffffffffffffffffffinfhumanfseraforfplasmaTreponema pallidum
OneftestOnefrun
Oneffinalfresult
I N N O - L I A ™ S y p h i l i s S c o r e
48488. INNO-LIA™TSyphilisTScore
8.1TStripTcomposition
A purposefulTchoiceTofThighlyTpurifiedTsyntheticTpeptideandTrecombinantTproteins
TpN47
TpN17
TpN15
TmpA
AntigenTsource
• RecombinantTproteinsConformational antigensIncreased sensitivity
• SyntheticTpeptide-TveryTspecificTreaction
Higher specificity
What’sTinTaTline?
RecombinantTproteins
SyntheticTpeptide
}
INN
O-L
IA™
SC
OR
E S
AS
© F
ujir
ebio
Eur
ope
2014
-
SY
01
I N N O - L I A ™ S y p h i l i s S c o r e
4949
8.2gStripginterpretation
InterpretationgofgthegINNO-LIA™gSyphilisgScore
Positive: -RtwoRorRmoreRsyphilisRantigenRlinesRshowaRreactivityRofR±RorRhigher
Indeterminate: -RoneRsyphilisRantigenRlineRshowsaRreactivityRofR1+RorRhigher
Negative: -RallRsyphilisRantigenRlinesRhaveaRnegativeRreactivityRrating
-RifRoneRsyphilisRantigenRlineRscoresR±
Backgroundicontrol
Leveli3+
Leveli1+
Leveli+/-
TpN47
TpN17
TpN15
TmpA
Positive Positive Negativecontrol
INN
O-L
IA™
RSC
OR
ERS
AS
©RF
ujir
ebio
REur
opeR
2014
R- Indeterminate Negativecontrol
SY
SY
SY
SY
SY
I N N O - L I A ™ S y p h i l i s S c o r e
5050
8.3uTestuperformance
Sensitivity
ClinicaluandupotentiallyuinterferingusamplesAuto)immuneGastroGeriatricsHIVIntensive9careNefroPediatricsObstetricsRheumatoid9factorSurgeryGranduTotal
Neg2Ejj
4™Fjj
%E22j
166
Ind™™™™™™™™™™0
Pos™™™™2™™™™™1
Number2Ejj
4™jjj
%E22j
167
Specificity
The9specificity9was9determined9on9%™™9blood9donors(922F9samples9from9hospitali)zed9patients9wincluding9pregnant9womenl9and94™9samples9containing9potentiallyinterfering9substances.
BloodudonorsA9total9of9%™™9blood9donors9were9tested9internally9with9the9INNO)LIA™9SyphilisScore9using9the9manual9procedure.9After9initial9testing(96E™9samples9were9scorednegative9and92™9samples9scored9indeterminately(9resulting9in9an9initial9specificityof9E©.F939w6E™L%™™l.
ClinicaluandupotentiallyuinterferingusamplesA9total9of92©F9clinical9and9potentially9interfering9samples9were9tested9internally.All9but9one9sample9reacted9negative.9This9sample9was9retested9in9duplicate9andwas9found9negative9twice.9On9this9set9of9samples(9an9initial9specificity9of9EE./93w2©©L2©Fl9was9obtained9and9after9retesting9the9specificity9is92™™93.
©9F
ujir
ebio
9Eur
ope9
6™2/
9)IN
NO
)LIA
™9S
CO
RE
9SA
S
A9total9of96™29syphilis)positive9samples(9were9tested9internally9with9theINNO)LIATM9Syphilis9Score9using9the9manual9procedure.9All9samples9gave9apositive9result9on9the9assay(9resulting9in92™™939sensitivity9w6™2L6™2l.
I N N O - L I A ™ S y p h i l i s S c o r e
5151
gfvhPublications
Articles
™fhEbelhA-hVannestehL-hCardinaelshM-hSablonhE-hSamsonhI-hDehBosscherehK-HulstaerthF-hZreinhMfhJhClinhMicrobiolhyOOO;pg7y™69™)f
ValidationhofhthehINNO9LIA™hSyphilishKithashahConfirmatoryAssayhfor Treponema pallidium Antibodies
Sensitivity7h))f%J
Specificity7h))f6J;includinghindeterminates3
Conclusion
ThisB singleB multiparametricB assayB providesB reliableB confirmatoryB diagnosticinformationBthatBmustBcurrentlyBbeBobtainedBbyBtheBperformanceBandBinterpretationofBresultsBofBaBcombinationBofBserologicalBassaysw
yfhHagedornhH9J-hKraminer9HagedornhA-hDehBosscherehK-hHulstaerthF-hPottelH-hZreinhMfhJhClinhMicrobiolhyOOy;vO7)(p9(gf
EvaluationhofhINNO9LIA™hSyphilishAssayhashaConfirmatoryhtesthfor Syphilis
Sensitivity7h™OOJ
Specificity7h))fpJ;includinghindeterminates3
Conclusion
ComparedB toB TPHA andB IgG)FTA)ABS<B theB INNO)LIA™B SyphilisB gavesignificantlyB higherB numberB =P=RwR©EB andB P<RwRRRE<B respectively0B ofB currentresultsB thanB eitherB ofB theB otherB twoB testswB TheB multiparameterB INNO)LIA™SyphilisBassayB isBaBusefulBconfirmatoryB testB forBsyphilisBbecauseB itB increasesB thereliabilityBofBsyphilisBdiagnosisBwithBrespectBtoBcurrentBconventionalBtechniquesw
INN
O)L
IA™
BSC
OR
EBS
AS
©BF
ujir
ebio
BEur
opeB
©RE4
B)
I N N O - L I A ™ S y p h i l i s S c o r e
5252
”ylFrenchlP“lGomberglM“lJanierlM“lSchmidtlB“lvanlVoorstlVaderlP“YounglH“lInternationallJournalloflSTDl2lAIDSl)EE1Rl)E5l”EEp”E1
INNO-LIA™.Syphilis.Score.is.referenced.as.the.gold.standard.method,.recom-mended.by.European.Guidelines.as.a.reproducible.and.accurate.confirmatory.testfor.Syphilis.diagnosis.
“ThelIgGlimmunoblotlusinglrecombinantlantigenlislrecommendedaslalsupplementarylconfirmatoryltest“lwhenlalpositivelEIAlscreeningltest
islnotlconfirmedlbylthelTPPAl9TPHA;lorlalpositivel TPPAl9TPHA;screeningltestslislnotlconfirmedlbylthelEIAltesty
ThelFTApabslislnotlrecommendedlaslalstandardlconfirmatoryltesty”
4ylChucklA“lOhinmaalA“lTilleylP“lSinghlS“lJacobslPylInternationallJournallofSTDl2lAIDSl)EE8Rl(15”1”p”11
Despite.relative.high.cost.of.reagents.for.Syphilis.diagnosis.by.means.of.EIA.andINNO-LIA™.Syphilis.Score,.this.algorithm.remains.less.costly.and.at.the.sametime.more.cost.effective
Alcohortl9C(C)”lprenatalldiagnosislsampleslandl”8()4lnonpprenatal;simulationlstudylwaslconducted“lwherelcostlandleffectivenesslof
)ltestinglalgorithms5lRPRl-lTPPAl9TPHA;landlEIAl-lIgGlimmunoblotwerelcomparedylCostlincludedltestslreagentslandllabour“ltreatment
andlfollowlupletc“lwhileleffectivenesslmeantlcostloflfalselresults“iyeylcostloflobtaininglcorrectldiagnosisy
(ylTotallcostlwerel5l Can&l4l))Cl1E)lforlRPRl-lTPPA9TPHA;andlCan&l4l(41l”C”lforlEIAl-lIgGlimmunoblot
)ylAlgorithmlEIAl-IgGlimmunoblotlwaslmorelcostleffective
IUSTI5l)EE8lEuropeanlGuidelineslonlthelManagementloflSyphilis
Conclusion
Costleffectivenessloflenzymelimmunoassayandlimmunoblotltestinglforltheldiagnosisloflsyphilis
Conclusion
8y4lPublications
INN
O-L
IA™
.SC
OR
E.S
AS
©.F
ujir
ebio
.Eur
ope.
2014
.-
53538.5 INNO-LIA™CSyphilisCScoreCvs
Mikrogen recomLineCTreponemaCIgG
I N N O - L I A ™ S y p h i l i s S c o r e
Mikrogen recomLine6Treponema6IgG6was6compared6to6INNO9LIA™6Syphilis6Score5R6h6protocol6on6results6obtained6from6R26syphilis6IgG6samples86The6following6table6andfigures6give6an6overview6of6the6scoring6of6both6assays8
Comparison6between6the6INNO9LIA™6Syphilis6Score6andMikrogen recomLine6Treponema6IgG
Conclusion
INNO9LIA™6Syphilis6Score6(5R6h) positivity was respectively 8 % higher,
indeterminates were 3 % lower:6and6the negativity was 5 % lower than6MikrogenrecomLine6Treponema6IgG6for6the6R26tested6syphilis6IgG6samples86Three6samples6testednegative6on6Mikrogen recomLine6Treponema6IgG:6none6of6the6samples6tested6negativeon6INNO9LIA™6Syphilis6Score86The6INNO9LIA™6Syphilis6Score65R6h6protocol6givesmore clear-cut results.
INNO-LIA™CSyphilisCScoreC16ChPositive:6jF6.:6Indeterminate:6E6.:6Negative:626.
Mikrogen recomLineCTreponemaCIgGPositive6j26.:6Indeterminate:646.:6Negative:646.
INNO9LIA™6Syphilis6Score65R6h
NEG IND POS TOTAL
MikrogenrecomLine
Treponema6IgG
NEG 2 2 D D
IND 2 2 D D
POS 2 5 4D 43
TOTAL 2 5 4j R2
INNO-LIA™TSyphilisTScoreT16Th
Positive Indeterminate Negative
Mikrogen recomLineTTreponemaTIgG
Positive Indeterminate Negative
INN
O9L
IA™
6SC
OR
E6S
AS
©6F
ujir
ebio
6Eur
ope6
E253
69
Comparison study performed at Fujirebio Europe N.V. in 2013
54548.6 INNO-LIA™ Syphilis Score vs Trep-Sure™
I NN O- L I A ™ S y p h i l i s S c o r e
Trep%Sure™0was0compared0to0INNO%LIA™0Syphilis0Score0EF0h0protocol0on0resultsobtained0from0F30syphilis0IgG0samples20The0following0table0and0figures0show0anoverview0of0the0scoring0of0both0assays2
Comparison0between0the0INNO%LIA™0Syphilis0Score0andTrep%Sure™
Conclusion
INNO%LIA™0Syphilis0Score0,EF0hP positivity was respectively 1 % higher andindeterminates were 2 % lower than0Trep%Sure™0for0the0F30tested0syphilis0IgG0samples2Two0samples0tested0negative0on0Trep%Sure™80none0of0the0samples0tested0negative0onINNO%LIA™0Syphilis0Score20The0INNO%LIA™0Syphilis0Score0EF0h0protocol0gives0moreclear-cut results2
INNO-LIA™ Syphilis Score 16 hPositive:0940C80Indeterminate:0D0C80Negative:030C
Trep-Sure™Positive09j0C80Indeterminate:030C80Negative:050C
INNO%LIA™0Syphilis0Score0EF0h
NEG IND POS TOTAL
Trep%Sure™
NEG 3 3 D D
IND 3 3 3 3
POS 3 E ©j ©4
TOTAL 3 E ©9 F3
INNO-LIA™ Syphilis Score 16 h
Positive Indeterminate Negative
Trep-Sure™
Positive Indeterminate Negative
INN
O%L
IA™
0SC
OR
E0S
AS
©0F
ujir
ebio
0Eur
ope0
D3ER
0%
Comparison study performed at Fujirebio Europe N.V. in 2013